SAGA LSE Week ended 07 Aug 2026

Weekly Investor Report

Saga plc · Financial Services · Insurance - Diversified

Open interactive chart View report data
Latest close 738.0 GBP
9.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 31.7% above the Trend Line and sits at 98.4% of its 52-week range. The latest completed week returned 9.8%, after a 18.6% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.

Setup score 74 out of 100
Latest Close 738.0 GBP 7 Aug 2026
1W Return 9.8% latest completed week
4W Return 18.6% short-term follow-through
12W Return 41.9% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 85-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 13 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 9.8% Latest completed week; four-week move 18.6%. Indicator stack 100/80 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 5 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 31.7% above the Trend Line and sits at 98.4% of its 52-week range. The latest completed week returned 9.8%, after a 18.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9112-week average 0.91

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.91Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1313 reversal markers

No recent accumulation markers. 13 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 18.6% over four weeks, 41.9% over 12 weeks, and 322.7% over one year. The current trend has remained active for 85 consecutive weeks.

Performance by holding period

1W9.8%
4W18.6%
12W41.9%
26W41.9%
52W322.7%
Active trend streak85 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.40Latest activity-pressure read.
Pressure change283.9%Four-week change in activity pressure.
Leadership58.52Latest relative-leadership reading.
RS change15.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Jan 2026 Field coverage 85% Model confidence 72%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength51/100Blend of value, momentum, and quality. Underlying universe rank 50; rank 1 is best.
Value7/100Relative valuation strength. Underlying universe rank 94; rank 1 is best.
Quality89/100Profitability and accounting quality. Underlying universe rank 12; rank 1 is best.
Momentum100/100Medium-term price momentum. Underlying universe rank 1; rank 1 is best.
Growth88/100Revenue and earnings growth. Underlying universe rank 13; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework47/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
298.1x
Price divided by trailing earnings.
Price / sales
1.6x
Market value relative to trailing revenue.
EV / EBITDA
13.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
48.3%
Gross profit retained from each unit of revenue.
Operating margin
15.2%
Operating profit retained from revenue.
Free-cash-flow margin
15.3%
Free cash flow generated from revenue.
Return on invested capital
16.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
8.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 5 relevant articles.

0 positive · 5 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.2%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+13.4%Week of 17 Apr.
Worst week-15.1%Week of 13 Mar.
Latest week+9.8%Week of 7 Aug.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks0
Modest losses6
Sharp losses5
Recent vol7.7%13-week weekly-return volatility.
Base vol8.3%52-week weekly-return volatility.
Up/down split30/21Count of positive and negative weeks in the 52-week window.
Average skew8.2% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryGB Insurance - Diversified
4-week rank1 / 3
Group average9.6%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS66.7%positive relative leadership

Four-week leaders

SAGA · LSE18.6%AV · LSE7.7%HUW · LSE2.3%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape73/100

Trend, activity pressure, participation, and risk combine to a 73/100 tape read.

 Indicator analysis66/100

Latest 12-week confirmation: trend 12/12, activity pressure 3/12, relative leadership 12/12.

Activity pressure 0.91; 13 reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 80; Small Cap Core rank 93 SVQF47/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 138.5 of 260 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 5 relevant articles.

Saga plc Revenue Breakdown – LSE:SAGA Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026738.0 GBP9.8%560.3 GBP229.8 GBP0.4058.521.8MOn
31 Jul 2026672.0 GBP2.8%548.6 GBP226.0 GBP0.1748.012.9MOn
24 Jul 2026654.0 GBP-0.9%539.0 GBP222.5 GBP0.0848.701.8MOn
17 Jul 2026660.0 GBP6.1%529.9 GBP219.1 GBP-0.0254.991.8MOn
10 Jul 2026622.0 GBP-7.2%519.1 GBP215.6 GBP-0.2250.512.2MOn
3 Jul 2026670.0 GBP10.2%508.2 GBP212.5 GBP-0.4262.38567.4KOn
26 Jun 2026608.0 GBP9.4%494.8 GBP208.9 GBP-0.7453.011.0MOn
19 Jun 2026556.0 GBP-3.1%482.8 GBP205.8 GBP-0.7244.731.7MOn
12 Jun 2026574.0 GBP9.1%472.6 GBP203.0 GBP-0.6250.74530.0KOn
5 Jun 2026526.0 GBP-9.0%462.1 GBP200.1 GBP-0.6142.33297.6KOn
29 May 2026578.0 GBP4.1%453.4 GBP197.5 GBP-0.3558.734.9MOn
22 May 2026555.0 GBP6.7%443.3 GBP194.5 GBP-0.3254.925.6MOn
15 May 2026520.0 GBP-13.9%433.6 GBP191.6 GBP-0.2852.162.1MOn
8 May 2026604.0 GBP1.3%425.2 GBP189.0 GBP0.0979.652.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context